Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GBIDD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Monoclonal antibody B3-Lys-PE40 conjugate
|
|||||
| Synonyms |
B3LysPE40; B3 LysPE40; B3-LysPE40
Click to Show/Hide
|
|||||
| Organization |
Bethesda National Institutes of Health
|
|||||
| Drug Status |
Terminated
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Terminated
|
|||||
| Antibody Name |
Murine mAb B3
|
Antibody Info | ||||
| Antigen Name |
Poly [ADP-ribose] polymerase 1 (PARP1)
|
Antigen Info | ||||
| Payload Name |
LysPE40
|
Payload Info | ||||
| Therapeutic Target |
Eukaryotic elongation factor 2 (EEF2)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.